CEPA SCHWARZ PHARMA S L has a total of 16 patent applications. Its first patent ever was published in 2003. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are RALEXAR THERAPEUTICS INC, DUFFY KEVIN J and ANGIBAUD PATRICK RENE.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Brazil | 1 | |
#6 | Spain | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Benhamu Salama Bellinda | 8 |
#2 | Del Rio Zambrana Joaquin | 6 |
#3 | Frechilla Manso Diana | 6 |
#4 | Lopez Rodriguez Maria Luz | 5 |
#5 | Delgado Wallace Mercedes | 4 |
#6 | Marco Martinez Isabel | 3 |
#7 | Fuentes Cubero Jose Angel | 3 |
#8 | Lopez Rodriguez Luz M | 3 |
#9 | Valhondo Falcon Margarita | 2 |
#10 | Salama Bellinda Benhamu | 2 |
Publication | Filing date | Title |
---|---|---|
EP1674103A1 | Arylpiperazine derivatives and use thereof as 5-HT1A receptor ligands | |
ES2238015A1 | CICLOALCANODIONAS DERIVATIVES WITH NEUROPROTECTING ACTIVITY. | |
CN101172977A | Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |